Antifibrotic treatments have similar effects in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis.

Despite the development of cutting-edge genetic testing techniques and considerable progress in our understanding of the genetic basis of idiopathic pulmonary fibrosis (IPF), missing heritability and ...

Background: This study aims to elucidate the capability of periostin (POSTN) as a serum biomarker in diagnosing idiopathic pulmonary fibrosis (IPF), assessing disease severity, and predicting acute ...

UNAGI, a deep generative neural network, tracks IPF progression and identifies potential therapies by analyzing cell types and disease-related genes. The model autonomously learns and refines itself, ...

Insilico Medicine(“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the completion of patient enrollment in a Phase IIa study ...

Please provide your email address to receive an email when new articles are posted on . Patients with idiopathic pulmonary fibrosis coughed fewer times per hour after receiving a 14-day morphine ...

Roughly one in five (21 percent) of idiopathic pulmonary fibrosis (IPF) deaths might be related to occupational exposures, according to research published in the March 6 issue of the U.S. Centers for ...